In recent studies, due to the inhibition of the CCL2/CCR2 inflammatory pathway in the lung tissue of MCT-indued PAH rats, crocin has shown the clinical capacity to improve pulmonary vascular dysfunction and prevent PAH progress [105]. Here, CCL2 is linked to pulmonary arterial hypertension.